Wagner M. Zago's most recent trade in Prothena Corporation plc was a trade of 107,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 107,500 | 107,500 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2023 | 4,000 | 58,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.15 per share. | 02 Aug 2023 | 4,000 | 4,000 (0%) | 0% | 12.2 | 48,600 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 66.98 per share. | 02 Aug 2023 | 3,771 | 229 (0%) | 0% | 67.0 | 252,593 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 68.07 per share. | 02 Aug 2023 | 229 | 0 (0%) | 0% | 68.1 | 15,589 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.15 per share. | 05 Jul 2023 | 4,000 | 4,000 (0%) | 0% | 12.2 | 48,600 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2023 | 4,000 | 62,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 67.98 per share. | 05 Jul 2023 | 2,991 | 1,009 (0%) | 0% | 68.0 | 203,342 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 68.69 per share. | 05 Jul 2023 | 1,009 | 0 (0%) | 0% | 68.7 | 69,306 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.81 per share. | 07 Jun 2023 | 15,000 | 15,000 (0%) | 0% | 29.8 | 447,150 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 70.99 per share. | 07 Jun 2023 | 12,004 | 4,053 (0%) | 0% | 71.0 | 852,181 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 4,000 | 66,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.15 per share. | 07 Jun 2023 | 4,000 | 19,000 (0%) | 0% | 12.2 | 48,600 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 71.96 per share. | 07 Jun 2023 | 3,759 | 294 (0%) | 0% | 72.0 | 270,479 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 70.02 per share. | 07 Jun 2023 | 2,943 | 16,057 (0%) | 0% | 70.0 | 206,061 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 73.14 per share. | 07 Jun 2023 | 294 | 0 (0%) | 0% | 73.1 | 21,503 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 48,000 | 48,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2021 | 81,250 | 68,750 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.04 per share. | 22 Jun 2021 | 81,250 | 115,250 (0%) | 0% | 15.0 | 1,222,000 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 45.42 per share. | 22 Jun 2021 | 65,840 | 49,410 (0%) | 0% | 45.4 | 2,990,249 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 46.27 per share. | 22 Jun 2021 | 26,106 | 23,304 (0%) | 0% | 46.3 | 1,208,037 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2021 | 19,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.81 per share. | 22 Jun 2021 | 19,000 | 34,000 (0%) | 0% | 27.8 | 528,390 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 47.81 per share. | 22 Jun 2021 | 18,101 | 5,203 (0%) | 0% | 47.8 | 865,498 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2021 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.17 per share. | 22 Jun 2021 | 15,000 | 15,000 (0%) | 0% | 20.2 | 302,550 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 49.01 per share. | 22 Jun 2021 | 5,203 | 0 (0%) | 0% | 49.0 | 254,986 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 56,000 | 56,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 12 Feb 2021 | 18,750 | 0 (0%) | 0% | 20.0 | 375,008 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.53 per share. | 12 Feb 2021 | 18,750 | 18,750 (0%) | 0% | 13.5 | 253,688 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 18,750 | 31,250 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 17.07 per share. | 12 Feb 2021 | 7,560 | 0 (0%) | 0% | 17.1 | 129,049 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 7,560 | 7,540 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.41 per share. | 12 Feb 2021 | 7,560 | 7,560 (0%) | 0% | 6.4 | 48,460 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.41 per share. | 12 Feb 2021 | 7,540 | 7,540 (0%) | 0% | 6.4 | 48,331 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 25.50 per share. | 12 Feb 2021 | 7,540 | 0 (0%) | 0% | 25.5 | 192,270 | Ordinary Shares, par value $0.01 per share |
| Prothena Corporation plc | Wagner M. Zago | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 7,540 | 0 | - | - | Stock Option (Right to Buy) |